tiprankstipranks
Trending News
More News >

Merit Medical price target raised to $110 from $106 at Piper Sandler

Piper Sandler analyst Jason Bednar raised the firm’s price target on Merit Medical (MMSI) to $110 from $106 and keeps an Overweight rating on the shares. The firm is updating its Merit Medical model for several recent items, including the Biolife transaction announced earlier this week and the segment revenue recasting that was done effective Q1.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue